SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
plasmodium vivax
Journals
2
1
Nature Medicine
2
bmc systems biology
Research Groups
0
No Research Group Connected
Bibliographies
38
1
Plasmodium vivax readiness to transmit: implication for malaria eradication.
2
High-performance medicine: the convergence of human and artificial intelligence.
3
strategies for designing and monitoring malaria vaccines targeting diverse antigens
4
variants of the plasmodium vivax circumsporozoite protein (vk210 and vk247) in colombian isolates
5
cerebellar malaria due to plasmodium vivax in a child
6
caracterização de genótipos de plasmodium vivax na ilha de são luís, estado do maranhão characterization of plasmodium vivax genotypes on the island of são luís, state of maranhão
7
diagnostic performance characteristics of rapid dipstick test for plasmodium vivax malaria
8
acciones para el control de un brote de transmisión local de paludismo introducido en santiago de cuba actions for the control of a local transmission outbreak of malaria introduced in santiago de cuba
9
is primaquine useful and safe as true exo-erythrocytic merontocidal, hypnozoitocidal and gametocidal antimalarial drug?
10
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
11
Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia
12
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
13
Clinical utility of tafenoquine in the prevention of relapse of Plasmodium vivax malaria: a review on the mode of action and emerging trial data
14
Profiles of hematological parameters in Plasmodium falciparum and Plasmodium vivax malaria patients attending Tercha General Hospital, Dawuro Zone, South Ethiopia
15
Primaquine double dose for 7 days is inferior to single-dose treatment for 14 days in preventing Plasmodium vivax recurrent episodes in Suriname
16
Development of an HPLC-based guanosine monophosphate kinase assay and application to Plasmodium vivax guanylate kinase
17
Prevalence of Plasmodium falciparum Pfcrt and Pfmdr1 alleles in settings with different levels of Plasmodium vivax co-endemicity in Ethiopia.
18
Persistent ICT malaria P.f/P.v panmalarial and HRP2 antigen reactivity after treatment of Plasmodium falciparum malaria is associated with gametocytemia and results in false-positive diagnoses of Plasmodium vivax in convalescence.
19
A mathematical model for assessing the effectiveness of controlling relapse in Plasmodium vivax malaria endemic in the Republic of Korea.
20
Plasmodium vivax Liver and Blood Stages Recruit the Druggable Host Membrane Channel Aquaporin-3.
21
Out of Africa: origins and evolution of the human malaria parasites Plasmodium falciparum and Plasmodium vivax
22
Exposure to chloroquine in male adults and children aged 9-11 years with malaria due to Plasmodium vivax
23
A Prospective Comparative Study of Knowlesi, Falciparum, and Vivax Malaria in Sabah, Malaysia: High Proportion With Severe Disease From Plasmodium Knowlesi and Plasmodium Vivax But No Mortality With Early Referral and Artesunate Therapy
24
blood-stage plasmodium vivax antibody dynamics in a low transmission setting: a nine year follow-up study in the amazon region.
25
hubungan kadar hemoglobin dengan respon sitokin proinflamasi dan anti inflamasi pada penderita infeksi plasmodium falciparum dan plasmodium vivax di timika, papua tahun 2010
26
genomic analyses reveal the common occurrence and complexity of plasmodium vivax relapses in cambodia
27
chemoresistance of plasmodium falciparum and plasmodium vivax parasites in brazil: consequences on disease morbidity and control
28
validation of plasmodium vivax centromere and promoter activities using plasmodium yoelii.
29
malária não complicada por plasmodium vivax e p. falciparum no brasil: evidências sobre fármacos isolados e associações medicamentosas empregados em esquemas terapêuticos recomendados pelo protocolo terapêutico oficial uncomplicated plasmodium vivax and p. falciparum malaria in brazil: evidence on single and combined drug treatments recommended by official guidelines
30
congenital malaria due to plasmodium vivax infection in a neonate
31
alterations in cytokines and haematological parameters during the acute and convalescent phases of plasmodium falciparum and plasmodium vivax infections
32
infection of anopheles darlingi fed on patients infected with plasmodium vivax before and during treatment with chloroquine plus primaquine in costa marques, rondônia, brazil
33
hemophagocytic lymphohistiocytosis complicating dengue and plasmodium vivax coinfection
34
the vivax surveyor: online mapping database for plasmodium vivax clinical trials
35
Relapse of Plasmodium vivax and Plasmodium ovale malaria with and without primaquine treatment in a non-endemic area
36
Evaluation of CareStart™ malaria Pf/Pv combo test for Plasmodium falciparum and Plasmodium vivax malaria diagnosis in Butajira area, south-central Ethiopia - Malaria Journal
37
Hypnozoite dynamics for Plasmodium vivax malaria: the epidemiological effects of radical cure
38
An activation-clearance model for Plasmodium vivax malaria